维普期刊资源整合服务平台（V6.5）

767篇 您的检索式：作者名="Krum H"

选中清除导出查看参考文献查看引证文献引用追踪共39页首页上一页第1页下一页末页 /39 跳转

	题名	作者	年代	出处	被引量
1	接受安体舒通治疗的慢性心力衰竭患者还需要给予β受体阻滞剂吗?显示文摘	Krum H Mohacsi P Katus H A 任美峰	2006	中国处方药2006，5，1：	8
2	Role of valsartan and other angiotensin receptor blocking agents in the managenenl of cardiovascular disease 显示文摘	Martin J Krum H	2002	Pharmacol Res2002，46，3：	2
3	Steady State plasma- noradrenaline kinetics in quadriplegic chronic spinal cordinjury patients 显示文摘	Krum H Brown D J Rowe P R	1990	J Auton Pharmacol1990，10，4：	1
4	Effect of carvedilol on survival in severe chronic heart failure显示文摘	Packer M Coats AJ Fowler MB Katus HA Krum H Mohacsi P	2001	N Engl J Med2001，344，：	1
5	Catheter-based renal sympathetic denervation for resistant hypertension:a multicentre safety and proof-of-principle cohort study显示文摘	Krum H Schlaich M Whitbourn R		0，，9671：	1
6	Safety and efficacy of out patient nesiritidein patients with advanced heart failure: results of thesecond Follow-Up Serial Infusions of Nesiritide( FUSION ]I ) tri- al显示文摘	Yancy CW Krum H Massie BM	2008	Circ Heart Fail2008，1，1：	1
7	RAAS inhibitors and cardiovascular protection in large scale trials显示文摘	von Lueder TG Krum H	2013	Cardiovase Drugs Ther2013，27，2：	1
8	The Second Follow-up Serial Infusions of Nesiritide(FUSIONII)trial for advanced heart failure:study rationale and designAm显示文摘	YANCY C W KRUM H MASSIE B M	2007	Heart J2007，153，：	1
9	Meta-Analysis of effect of beta-blocker therapy on mortality on NYHA class Ⅳ CHF patients显示文摘	Whorlow S	1999	Circulation(Sepplement 1)1999，100，18：	1
10	Statins and symptomatic chronic systolic heart failure a post-hoc analysis of 5 010 patients enrolled in Val-HeFT显示文摘	Krum H Latini R Maggioni AP	2007	Int J Cardiol2007，119，1：	1
11	Beta-blockers in chronit heart failure;what have we learned?What do we still need to know显示文摘	Krum H	2003	Current op in pharmacol2003，3，：	1
12	Importance of renin in blood pressure regulation and therapeutic potential of renin inhibition 显示文摘	Ferro A Gilbert R Krum H	2006	Int J Clin Pract2006，60，：	1
13	Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial):a randomised controlled trial显示文摘	Esler MD Krum H Sobotka PA	2010	Lancet2010，376，9756：	1
14	Renal sympatheticnerve ablation for uncontrolled hypertension显示文摘	Schlaich MP Sohotka PA Krum H		0，，9：	1
15	Catheter-based renal sympathetic denervation for resistant hypertension :a multicentre safety and proof-of-pnncple cohort study 显示文摘	Krum H Schlaich M Whitboum R	2009	Lancet2009，373，：	1
16	Novel therapies blocking the reninangiotensin-aldosterone system in the management of hypertension and related disorders 显示文摘	Krum H Gilbert RE	2007	J Hypertens2007，25，1：	1
17	Baseline predic, tors of tolerability to carvedilol in patients with chronic heart failure显示文摘	KRUM H NINIO D MacDONALD P	2000	Heart2000，849，6：	1
18	Tolerability of beta-blockers in elderly patients with chronic heart failure:the COLA II study显示文摘	Krum H Hill J Fruhwald F	2006	Eur J Heart Fail2006，8，3：	1
19	Medical therapy for chronic heart failure 显示文摘	Krum H Teerlink J R	2011	Lancet2011，378，9792：	1
20	Renal sympathetic denervation for treatment of drug-resistant hypertension:one-year results from the symplicity HTN-2 randomized,controlled trial显示文摘	Esler MD Krum H Schlaich M	2012	Circulation2012，126，25：	1

返回顶部每页显示：

共39页首页上一页第1页下一页末页 /39 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示